July 3 (Reuters) - Suda Pharmaceuticals Ltd SUD.AX :
* INTENDS TO CONDUCT 1 FOR 1 NON-RENOUNCEABLE ENTITLEMENT OFFER OF FULLY PAID ORDINARY SHARES IN CO
* OFFER PRICE FOR ENTITLEMENT OFFER WILL BE $0.025 PER SHARE
* FOR EVERY 3 NEW SHARES, SHAREHOLDERS WILL RECEIVE 1 NEW OPTION
* NON-RENOUNCEABLE ENTITLEMENT OFFER TO RAISE ABOUT $3.56 MILLION